Screener
Evolent Health, Inc. EVH Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:53 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628908-26-000086
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss on lease termination | — | — | — | 1,906 |
| Change in fair value of contingent consideration | — | 3,206 | — | 2,926 |
| Operating expenses | 662,081 | 445,499 | 1,168,926 | 930,770 |
| Operating loss | (9,561) | (1,171) | (20,160) | (2,793) |
| Interest income | 703 | 1,084 | 1,717 | 2,358 |
| Interest expense | (16,859) | (11,601) | (33,727) | (21,986) |
| Gain (loss) from equity method investees | (41) | 197 | (52) | 178 |
| Loss on option exercise | — | (196) | — | (52,544) |
Item 1. Financial Statements
FAQ
- What is Evolent Health, Inc.'s operating income?
- Evolent Health, Inc. (EVH) reported operating income of -$9.56M in Q2 2026.
- How has Evolent Health, Inc.'s operating income changed year-over-year?
- Evolent Health, Inc.'s operating income decreased by 716.5% year-over-year, from -$1.17M to -$9.56M.
- What is the long-term trend for Evolent Health, Inc.'s operating income?
- Over 3 years (2021 to 2025), Evolent Health, Inc.'s operating income has grown at a 113.1% compound annual growth rate (CAGR), from -$42.41M to -$410.14M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Evolent Health, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude